The Cyclin-Dependent Kinase Inhibitor p21 Is a Crucial Target for Histone Deacetylase 1 as a Regulator of Cellular Proliferation

REFERENCES

• Adnane, J., R. J. Jackson, S. V. Nicosia, A. B. Cantor, W. J. Pledger, and S. M. Sebti. 2000. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene 19:5338–5347.
   PubMed Web of Science ®Google Scholar
• Archer, S. Y., S. Meng, A. Shei, and R. A. Hodin. 1998. p21Waf1 is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. U. S. A. 95:6791–6796.
   PubMed Web of Science ®Google Scholar
• Bargonetti, J., I. Reynisdottir, P. N. Friedman, and C. Prives. 1992. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev. 6:1886–1898.
   PubMed Web of Science ®Google Scholar
• Bartl, S., J. Taplick, G. Lagger, H. Khier, K. Kuchler, and C. Seiser. 1997. Identification of mouse histone deacetylase 1 as a growth factor-inducible gene. Mol. Cell. Biol. 17:5033–5043.
   PubMed Web of Science ®Google Scholar
• Bhaskara, S., B. J. Chyla, J. M. Amann, S. K. Knutson, D. Cortez, Z. W. Sun, and S. W. Hiebert. 2008. Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol. Cell 30:61–72.
   PubMed Web of Science ®Google Scholar
• Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597–601.
   PubMed Web of Science ®Google Scholar
• Brown, J. P., W. Wei, and J. M. Sedivy. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277:831–834.
   PubMed Web of Science ®Google Scholar
• Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552–557.
   PubMed Web of Science ®Google Scholar
• Burdon, T., A. Smith, and P. Savatier. 2002. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12:432–438.
   PubMed Web of Science ®Google Scholar
• Campisi, J. 2000. Cancer, aging and cellular senescence. In Vivo 14:183–188.
   PubMed Web of Science ®Google Scholar
• Chang, S., T. A. McKinsey, C. L. Zhang, J. A. Richardson, J. A. Hill, and E. N. Olson. 2004. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol. Cell. Biol. 24:8467–8476.
   PubMed Web of Science ®Google Scholar
• Decesse, J. T., S. Medjkane, M. B. Datto, and C. E. Cremisi. 2001. RB regulates transcription of the p21/WAF1/CIP1 gene. Oncogene 20:962–971.
   PubMedGoogle Scholar
• Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675–684.
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92:9363–9367.
   PubMed Web of Science ®Google Scholar
• Dyson, N., P. M. Howley, K. Munger, and E. Harlow. 1989. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937.
   PubMed Web of Science ®Google Scholar
• Glaser, K. B., J. Li, M. J. Staver, R. Q. Wei, D. H. Albert, and S. K. Davidsen. 2003. Role of class I and class II histone deacetylases in carcinoma cells using siRNA. Biochem. Biophys. Res. Commun. 310:529–536.
   PubMed Web of Science ®Google Scholar
• Glozak, M. A., N. Sengupta, X. Zhang, and E. Seto. 2005. Acetylation and deacetylation of non-histone proteins. Gene 363:15–23.
   PubMed Web of Science ®Google Scholar
• Glozak, M. A., and E. Seto. 2007. Histone deacetylases and cancer. Oncogene 26:5420–5432.
   PubMed Web of Science ®Google Scholar
• Gregoretti, I. V., Y. M. Lee, and H. V. Goodson. 2004. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338:17–31.
   PubMed Web of Science ®Google Scholar
• Gui, C. Y., L. Ngo, W. S. Xu, V. M. Richon, and P. A. Marks. 2004. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc. Natl. Acad. Sci. U. S. A. 101:1241–1246.
   PubMed Web of Science ®Google Scholar
• Haberland, M., A. Johnson, M. H. Mokalled, R. L. Montgomery, and E. N. Olson. 2009. Genetic dissection of histone deacetylase requirement in tumor cells. Proc. Natl. Acad. Sci. U. S. A. 106:7751–7755.
   PubMed Web of Science ®Google Scholar
• Harvey, M., A. T. Sands, R. S. Weiss, M. E. Hegi, R. W. Wiseman, P. Pantazis, B. C. Giovanella, M. A. Tainsky, A. Bradley, and L. A. Donehower. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8:2457–2467.
   PubMed Web of Science ®Google Scholar
• Hauser, C., B. Schuettengruber, S. Bartl, G. Lagger, and C. Seiser. 2002. Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation. Mol. Cell. Biol. 22:7820–7830.
   PubMedGoogle Scholar
• Henrique, D., J. Adam, A. Myat, A. Chitnis, J. Lewis, and D. Ish Horowicz. 1995. Expression of a Delta homologue in prospective neurons in the chick. Nature 375:787–790.
   PubMedGoogle Scholar
• Hogan, B., R. Beddington, F. Constantini, and E. Lacy. 1994. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
   Google Scholar
• Jacobs, J. J., K. Kieboom, S. Marino, R. A. DePinho, and M. van Lohuizen. 1999. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397:164–168.
   PubMed Web of Science ®Google Scholar
• Kamijo, T., F. Zindy, M. F. Roussel, D. E. Quelle, J. R. Downing, R. A. Ashmun, G. Grosveld, and C. J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649–659.
   PubMed Web of Science ®Google Scholar
• Lagger, G., A. Doetzlhofer, B. Schuettengruber, E. Haidweger, E. Simboeck, J. Tischler, S. Chiocca, G. Suske, H. Rotheneder, E. Wintersberger, and C. Seiser. 2003. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol. Cell. Biol. 23:2669–2679.
   PubMed Web of Science ®Google Scholar
• Lagger, G., D. O'Carroll, M. Rembold, H. Khier, J. Tischler, G. Weitzer, B. Schuettengruber, C. Hauser, R. Brunmeir, T. Jenuwein, and C. Seiser. 2002. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21:2672–2681.
   PubMed Web of Science ®Google Scholar
• Lee, Y. S., K. H. Lim, X. Guo, Y. Kawaguchi, Y. Gao, T. Barrientos, P. Ordentlich, X. F. Wang, C. M. Counter, and T. P. Yao. 2008. The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. Cancer Res. 68:7561–7569.
   PubMed Web of Science ®Google Scholar
• Lin, Y. C., J. H. Lin, C. W. Chou, Y. F. Chang, S. H. Yeh, and C. C. Chen. 2008. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Cancer Res. 68:2375–2383.
   PubMed Web of Science ®Google Scholar
• MagnaghiJaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. LeVillain, F. Troalen, D. Trouche, and A. HarelBellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601–605.
   PubMedGoogle Scholar
• Marks, P. A., V. M. Richon, T. Miller, and W. K. Kelly. 2004. Histone deacetylase inhibitors. Adv. Cancer Res. 91:137–168.
   PubMed Web of Science ®Google Scholar
• Marks, P. A., V. M. Richon, and R. A. Rifkind. 2000. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92:1210–1216.
   PubMed Web of Science ®Google Scholar
• Martin-Caballero, J., J. M. Flores, P. Garcia-Palencia, and M. Serrano. 2001. Tumor susceptibility of p21Waf1/Cip1-deficient mice. Cancer Res. 61:6234–6238.
   PubMed Web of Science ®Google Scholar
• Montgomery, R. L., C. A. Davis, M. J. Potthoff, M. Haberland, J. Fielitz, X. Qi, J. A. Hill, J. A. Richardson, and E. N. Olson. 2007. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 21:1790–1802.
   PubMed Web of Science ®Google Scholar
• Ocker, M., and R. Schneider-Stock. 2007. Histone deacetylase inhibitors: signalling toward p21cip1/waf1. Int. J. Biochem. Cell Biol. 39:1367–1374.
   PubMed Web of Science ®Google Scholar
• Pantoja, C., and M. Serrano. 1999. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 18:4974–4982.
   PubMed Web of Science ®Google Scholar
• Patel, D., A. Incassati, N. Wang, and D. J. McCance. 2004. Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins. Cancer Res. 64:1299–1306.
   PubMed Web of Science ®Google Scholar
• Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136.
   PubMed Web of Science ®Google Scholar
• Senese, S., K. Zaragoza, S. Minardi, I. Muradore, S. Ronzoni, A. Passafaro, L. Bernard, G. F. Draetta, M. Alcalay, C. Seiser, and S. Chiocca. 2007. Role for histone deacetylase 1 in human tumor cell proliferation. Mol. Cell. Biol. 27:4784–4795.
   PubMed Web of Science ®Google Scholar
• Sheng, Q., D. Denis, M. Ratnofsky, T. M. Roberts, J. A. DeCaprio, and B. Schaffhausen. 1997. The DnaJ domain of polyomavirus large T antigen is required to regulate Rb family tumor suppressor function. J. Virol. 71:9410–9416.
   PubMedGoogle Scholar
• Shin, M. K., S. Balsitis, T. Brake, and P. F. Lambert. 2009. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis. Cancer Res. 69:5656–5663.
   PubMed Web of Science ®Google Scholar
• Stead, E., J. White, R. Faast, S. Conn, S. Goldstone, J. Rathjen, U. Dhingra, P. Rathjen, D. Walker, and S. Dalton. 2002. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21:8320–8333.
   PubMed Web of Science ®Google Scholar
• Taplick, J., V. Kurtev, K. Kroboth, M. Posch, T. Lechner, and C. Seiser. 2001. Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1. J. Mol. Biol. 308:27–38.
   PubMed Web of Science ®Google Scholar
• Tiemann, F., and W. Deppert. 1994. Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences. J. Virol. 68:2869–2878.
   PubMedGoogle Scholar
• Trivedi, C. M., Y. Luo, Z. Yin, M. Zhang, W. Zhu, T. Wang, T. Floss, M. Goettlicher, P. R. Noppinger, W. Wurst, V. A. Ferrari, C. S. Abrams, P. J. Gruber, and J. A. Epstein. 2007. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat. Med. 13:324–331.
   PubMed Web of Science ®Google Scholar
• Vaziri, C., L. Stice, and D. V. Faller. 1998. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ. 9:465–474.
   PubMedGoogle Scholar
• Vega, R. B., K. Matsuda, J. Oh, A. C. Barbosa, X. Yang, E. Meadows, J. McAnally, C. Pomajzl, J. M. Shelton, J. A. Richardson, G. Karsenty, and E. N. Olson. 2004. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119:555–566.
   PubMed Web of Science ®Google Scholar
• Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574–578.
   PubMed Web of Science ®Google Scholar
• Warrener, R., H. Beamish, A. Burgess, N. J. Waterhouse, N. Giles, D. Fairlie, and B. Gabrielli. 2003. Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints. FASEB J. 17:1550–1552.
   PubMed Web of Science ®Google Scholar
• Weichert, W., A. Roske, S. Niesporek, A. Noske, A. C. Buckendahl, M. Dietel, V. Gekeler, M. Boehm, T. Beckers, and C. Denkert. 2008. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin. Cancer Res. 14:1669–1677.
   PubMed Web of Science ®Google Scholar
• Wharton, W., J. Savell, W. D. Cress, E. Seto, and W. J. Pledger. 2000. Inhibition of mitogenesis in BALB/c-3T3 cells by Trichostatin A. Multiple alterations in the induction and activation of cyclin-cyclin-dependent kinase complexes. J. Biol. Chem. 275:33981–33987.
   PubMedGoogle Scholar
• Wilson, A. J., D. S. Byun, S. Nasser, L. Murray, K. Ayyanar, D. Arango, M. Figueroa, A. Melnick, G. D. Kao, L. H. Augenlicht, and J. M. Mariadason. 2008. HDAC4 promotes growth of colon cancer cells via repression of p21. Mol. Biol. Cell. 19:4062–4075.
   PubMed Web of Science ®Google Scholar
• Wilson, A. J., D. S. Byun, N. Popova, L. B. Murray, K. L'Italien, Y. Sowa, D. Arango, A. Velcich, L. H. Augenlicht, and J. M. Mariadason. 2006. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 281:13548–13558.
   PubMed Web of Science ®Google Scholar
• Ylikorkala, A., D. J. Rossi, N. Korsisaari, K. Luukko, K. Alitalo, M. Henkemeyer, and T. P. Makela. 2001. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 293:1323–1326.
   PubMedGoogle Scholar
• Zhang, C. L., T. A. McKinsey, S. Chang, C. L. Antos, J. A. Hill, and E. N. Olson. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479–488.
   PubMed Web of Science ®Google Scholar
• Zimmermann, S., F. Kiefer, M. Prudenziati, C. Spiller, J. Hansen, T. Floss, W. Wurst, S. Minucci, and M. Gottlicher. 2007. Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res. 67:9047–9054.
   PubMed Web of Science ®Google Scholar
• Zupkovitz, G., J. Tischler, M. Posch, I. Sadzak, K. Ramsauer, G. Egger, R. Grausenburger, N. Schweifer, S. Chiocca, T. Decker, and C. Seiser. 2006. Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol. Cell. Biol. 26:7913–7928.
   PubMed Web of Science ®Google Scholar